Anterogen obtains Chinese patent related to clinical stem cell production

16:13
S. Korea not to attend Sado mine memorial: foreign ministry
16:01
Gyeongju blends old with new
16:01
[What to Play] Cozy songs to warm you up
16:01
[Weekender] Korea's traditional sauce culture gains global recognition
16:01
Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
16:01
At Gwangcheonok, try North Korean-style sundae gukbap
16:01
Over 80,000 malicious calls made to Seoul call center since 2020
12:52
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
11:45
BLACKPINK's Rose stays at No. 3 on British Official Singles chart with 'APT.'
21:05
What you need to know about Adani's US bribery indictment

Anterogen obtains Chinese patent related to clinical stem cell production

July 13, 2016 - 15:37 By 황유미

[DISCLOSURE] Anterogen (065660) has obtained a Chinese patent for autologous and allogenic adipose-derived stromal stem cell composition for treating fistulas, it announced on July 13.

황유미